RE n TOX 100 IU 1 vial

Patients should avoid alcohol for at least 24 hours before and after the procedure. Alcohol is a vasodilator that can increase blood flow to the injection sites, potentially worsening post-procedural edema and increasing the risk of bruising at the entry points.

Strictly contraindicated. No clinical safety data exists for botulinum toxin use during pregnancy. We defer all elective neurotoxin treatments until after childbirth to ensure the highest clinical safety standards are met.

Dosage is highly individualized based on the target area and muscle mass. For glabellar lines, the standard protocol involves five injection sites. Practitioners should evaluate if targeted micro-dosing is appropriate for subtle smoothing in early-stage aging. The 100 IU vial must be reconstituted with sterile, preservative-free 0.9% sodium chloride before use. A full therapeutic effect is typically observed within 3 days post-injection.

Common reactions include temporary injection site pain, localized swelling, and purple bruising. Some patients may experience a mild headache or eyelid ptosis (drooping) if the product migures. To ensure a quick recovery, patients should follow our expert aftercare guide (adapted for toxins) and utilize swelling reduction techniques. Any difficulty swallowing or severe muscle weakness should be reported to the clinician immediately.

RE n TOX acts as a neuro-muscular blocking agent by inhibiting the release of acetylcholine from nerve endings. This effectively prevents muscle contraction, allowing the overlying skin to smooth out. Unlike skin boosters that hydrate the dermis, RE n TOX addresses the muscular cause of dynamic wrinkles. This relaxation complements techniques like the Russian lips filler technique by reducing perioral muscle tension.

The formulation contains 100 units of purified Clostridium botulinum toxin type A. Depending on the specific batch, stabilizers may include Human Serum Albumin and Sodium Chloride, though some advanced formulations are protein-free.